About
Our new client is a biopharmaceutical company specializing in neuroscience, dedicated to the research, development, manufacturing, marketing, and sale of pharmaceuticals globally. For over 70 years, they have pioneered innovative therapies for brain diseases.
Project Overview
With AI becoming a crucial topic in nearly every industry, our client sought to explore AI and Generative AI capabilities to their advantage. At Crunch, we adeptly explore AI and believe in its power to improve every process.
Recognizing the significant impact of Large Language Model (LLM) technologies on their industry and their desire to remain at the forefront of innovation, the client asked us to identify key opportunities, prioritize them, and select the best implementation approaches.
Our AI engineers offer complete consultation and AI Proof of Concept services to determine if AI should be on their current agenda. We began by reviewing the business strategy to identify opportunities for LLM implementation, conducting stakeholder interviews to analyze AI opportunities across business workflows. We then prioritized potential AI use cases, evaluating them for technical feasibility and potential business impact.
After this initial assessment, we further prioritized potential AI use cases and found growth points.
Results
We created a deep review of AI capabilities for the client, so they can get acquainted with the emerging technologies and incorporate them into their final yearly tech strategy.
PROJECT INFO
Industry
Pharma
Location
Denmark
Technologies
LLM
Duration
1 week
Clients’ words
More case studies
Have a question?
Let’s get in touch! Leave your contact details and we will reply within 24 hours.
By submitting completed “Contact Us” form, your personal data will be processed by Crunch & its subsidiary entities worldwide. Please read our Privacy Notice for more information. If you have any questions regarding your rights or would subsequently decide to withdraw your consent, please send your request to us.